IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9492398 B1

PDFFull Text
Date of Patent:
Nov. 15, 2016

Filed:

Feb. 24, 2012

Nanocapsulation of essential oils for preventing or curing infectious diseases alone or with an antibiotic

Applicants:

Elisabeth Rossines, Avesse, FR;

Marie Laure Joly-guillou, Angers, FR;

Patrick Saulnier, Marigne, FR;

Jean Pierre Benoit, Angers, FR;

Inventors:

Elisabeth Rossines, Avesse, FR;

Marie Laure Joly-Guillou, Angers, FR;

Patrick Saulnier, Marigne, FR;

Jean Pierre Benoit, Angers, FR;

Assignees:

Eydo Pharma, Romorantin Lanthenay, FR;

Institut National de la Sante et de la Recherche Medicale, Paris, FR;

Université d'Angers, Anders, FR;

Attorney:

Kunser & Jaffe

Primary Examiner:

Johann R Richter

Assistant Examiner:

Danielle Sullivan

Int. Cl.
CPC ...
A61K 9/51 (2006.01); A61K 9/107 (2006.01); A61K 31/015 (2006.01); A61K 31/05 (2006.01); A61K 31/085 (2006.01); A61K 31/11 (2006.01); A61K 31/35 (2006.01); A61K 31/407 (2006.01); A61K 31/424 (2006.01); A61K 31/43 (2006.01); A61K 31/431 (2006.01); A61K 31/4412 (2006.01); A61K 31/47 (2006.01); A61K 31/496 (2006.01); A61K 31/664 (2006.01); A61K 31/733 (2006.01); A61K 45/06 (2006.01); A61K 36/15 (2006.01); A61K 36/53 (2006.01); A61K 36/54 (2006.01); A61K 36/61 (2006.01); A01N 65/00 (2009.01); A01N 25/28 (2006.01); A01N 65/22 (2009.01); A01N 65/24 (2009.01); A01N 65/28 (2009.01);
U.S. Cl.
CPC ...
A61K 9/51 (2013.01); A01N 25/28 (2013.01); A01N 65/00 (2013.01); A01N 65/22 (2013.01); A01N 65/24 (2013.01); A01N 65/28 (2013.01); A61K 9/1075 (2013.01); A61K 9/5123 (2013.01); A61K 9/5146 (2013.01); A61K 31/015 (2013.01); A61K 31/05 (2013.01); A61K 31/085 (2013.01); A61K 31/11 (2013.01); A61K 31/35 (2013.01); A61K 31/407 (2013.01); A61K 31/424 (2013.01); A61K 31/43 (2013.01); A61K 31/431 (2013.01); A61K 31/4412 (2013.01); A61K 31/47 (2013.01); A61K 31/496 (2013.01); A61K 31/664 (2013.01); A61K 31/733 (2013.01); A61K 36/15 (2013.01); A61K 36/53 (2013.01); A61K 36/54 (2013.01); A61K 36/61 (2013.01); A61K 45/06 (2013.01);
Abstract

A composition, an encapsulated composition and/or nanoparticles comprising at least one essential oil having a large spectrum antibacterial, antiparasitic, antifungal activity and/or a plant antipathogen, optionally at least one antibiotic and optionally a pharmaceutically acceptable carrier is disclosed. Methods for treating infectious diseases and especially bacterial, parasitic, fungal and/or plant infectious by using this composition, encapsulated composition and/or nanoparticles are also disclosed.

Find Patent Forward Citations

Loading…